Clinical Trial Update: Xofluza-Wearables Feasibility-Study [Phase 4]

View source ↗

Summary

Phase 4 wearable-feasibility study evaluating Xofluza (baloxavir marboxil) completed, assessing wearable data collection in influenza and coronavirus infections…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infections

Drugs mentioned

• XOFLUZA (baloxavir marboxil)

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Infection, Coronavirus, Infections | Phase 4 | Status: COMPLETED